drugset / Trial / NCT00017082

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

NCT00017082 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of oxaliplatin in treating patients who have recurrent metastatic colorectal cancer.

Timeline

Start
2001-04
Primary completion
2003-06
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule — Intravenous

Indications